MENU
EDSA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Edesa Biotech (EDSA) Ownership - Who owns Edesa Biotech?

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases... Show more

Profile

Industry
N/A
Address
100 Spy Court
Phone
+1 289 800-9600
Employees
16
Web
https://www.edesabiotech.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.87M
P/E Ratio
N/A
Total Cash
13.9M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-0.19
Dividend Yield
N/A
Total Cash/Share
1.98
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

EDSA
Capitalization
13.9M
P/E Ratio
N/A
Risk (Beta)
-0.19
Dividend Yield
N/A
Total Cash
13.9M
Total Cash/Share
1.98
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
6.35M
P/B Ratio
2.18
Cash Flow
N/A
Earnings
-1.55
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
54.3M
Current Ratio
15.73
Current Revenue Per Employee
41.67
Dividends Per Share - Security
N/A
EBITDA
-5.68M
Float
N/A
Float - Current
N/A
Gross Income Margin
-362.80
Revenue To Assets
-50.92
Shares Held By Institutions
6.84M
Shares Outstanding - Current
7.02M
Total Liabilities
915K
Total Volume MTD
N/A
Value
-1
Gain YTD
17.560
View a ticker or compare two or three
EDSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Spy Court
Phone
+1 289 800-9600
Employees
16
Web
https://www.edesabiotech.com